Fan, Mengqiang
Tong, Peijian
Yan, Li
Li, Ting
Ren, Jiadan
Huang, Jiefeng
Du, Wenxi
Zhou, Li
Shan, Letian
Funding for this research was provided by:
Zhejiang Provincial Key Research and Development Program (2021C03046)
Natural Science Foundation of China (82074464, 82274373, 82104890, 81973873)
Article History
Received: 7 February 2023
Accepted: 5 June 2023
First Online: 19 June 2023
Declarations
:
: The animal use and experiments were approved by the Medical Norms and Ethics Committee of Zhejiang Chinese Medical University (Ethical number: 20190506–14). The use of SF from kOA patients was approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University (Ethical number: 2020-KL-151–01).
: Not applicable.
: The authors declare that they have no competing interests.